InspireMD (NSPR) Competitors

$1.15 -0.01 (-0.86%)

Closing price 05/8/2026 04:00 PM Eastern

Extended Trading

$1.21 +0.06 (+5.04%)

As of 05/8/2026 07:52 PM Eastern

NSPR vs. ELMD, INFU, CVRX, INGN, and KRMD

Should you be buying InspireMD stock or one of its competitors? The main competitors of InspireMD include Electromed (ELMD), InfuSystem (INFU), CVRx (CVRX), Inogen (INGN), and KORU Medical Systems (KRMD). These companies are all part of the "medical equipment" industry.

How does InspireMD compare to Electromed?

Electromed (NYSE:ELMD) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, risk, dividends, institutional ownership, media sentiment and profitability.

Electromed has a net margin of 11.34% compared to InspireMD's net margin of -413.96%. Electromed's return on equity of 15.71% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
InspireMD	-413.96%	-69.42%	-57.68%

Electromed has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500.

Electromed has higher revenue and earnings than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$68.86M	3.24	$5.15M	$1.03	26.15
InspireMD	$10.85M	4.97	-$19.92M	-$0.73	N/A

Electromed currently has a consensus target price of $36.67, suggesting a potential upside of 36.16%. InspireMD has a consensus target price of $4.50, suggesting a potential upside of 291.30%. Given InspireMD's higher possible upside, analysts plainly believe InspireMD is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.00
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

40.8% of Electromed shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 10.5% of Electromed shares are held by insiders. Comparatively, 34.1% of InspireMD shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, InspireMD had 14 more articles in the media than Electromed. MarketBeat recorded 14 mentions for InspireMD and 0 mentions for Electromed. InspireMD's average media sentiment score of 0.73 beat Electromed's score of 0.00 indicating that InspireMD is being referred to more favorably in the news media.

Company	Overall Sentiment
Electromed	Neutral
InspireMD	Positive

Summary

Electromed and InspireMD tied by winning 8 of the 16 factors compared between the two stocks.

How does InspireMD compare to InfuSystem?

InfuSystem (NYSE:INFU) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

InfuSystem has a net margin of 1.12% compared to InspireMD's net margin of -413.96%. InfuSystem's return on equity of 2.78% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InfuSystem	1.12%	2.78%	1.41%
InspireMD	-413.96%	-69.42%	-57.68%

71.1% of InfuSystem shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 10.8% of InfuSystem shares are held by company insiders. Comparatively, 34.1% of InspireMD shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

InfuSystem has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500.

In the previous week, InspireMD had 9 more articles in the media than InfuSystem. MarketBeat recorded 14 mentions for InspireMD and 5 mentions for InfuSystem. InspireMD's average media sentiment score of 0.73 beat InfuSystem's score of 0.29 indicating that InspireMD is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InfuSystem	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
InspireMD	4 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

InfuSystem presently has a consensus target price of $15.00, suggesting a potential upside of 78.36%. InspireMD has a consensus target price of $4.50, suggesting a potential upside of 291.30%. Given InspireMD's stronger consensus rating and higher possible upside, analysts clearly believe InspireMD is more favorable than InfuSystem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InfuSystem	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

InfuSystem has higher revenue and earnings than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InfuSystem	$143.44M	1.18	$870K	$0.38	22.13
InspireMD	$10.85M	4.97	-$19.92M	-$0.73	N/A

Summary

InfuSystem beats InspireMD on 9 of the 16 factors compared between the two stocks.

How does InspireMD compare to CVRx?

InspireMD (NYSE:NSPR) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

InspireMD currently has a consensus target price of $4.50, suggesting a potential upside of 291.30%. CVRx has a consensus target price of $11.50, suggesting a potential upside of 68.37%. Given InspireMD's higher possible upside, analysts plainly believe InspireMD is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00

CVRx has a net margin of -94.10% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
CVRx	-94.10%	-99.32%	-45.83%

InspireMD has higher earnings, but lower revenue than CVRx. CVRx is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.85M	4.97	-$19.92M	-$0.73	N/A
CVRx	$56.65M	3.19	-$53.31M	-$2.05	N/A

In the previous week, InspireMD had 10 more articles in the media than CVRx. MarketBeat recorded 14 mentions for InspireMD and 4 mentions for CVRx. InspireMD's average media sentiment score of 0.73 beat CVRx's score of 0.00 indicating that InspireMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InspireMD	4 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

InspireMD has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500. Comparatively, CVRx has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500.

44.8% of InspireMD shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 34.1% of InspireMD shares are owned by insiders. Comparatively, 13.9% of CVRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

InspireMD beats CVRx on 10 of the 16 factors compared between the two stocks.

How does InspireMD compare to Inogen?

InspireMD (NYSE:NSPR) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends.

In the previous week, InspireMD had 3 more articles in the media than Inogen. MarketBeat recorded 14 mentions for InspireMD and 11 mentions for Inogen. InspireMD's average media sentiment score of 0.73 beat Inogen's score of -0.20 indicating that InspireMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InspireMD	4 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inogen	1 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Inogen has a net margin of -7.08% compared to InspireMD's net margin of -413.96%. Inogen's return on equity of -12.68% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
Inogen	-7.08%	-12.68%	-8.14%

InspireMD has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.85M	4.97	-$19.92M	-$0.73	N/A
Inogen	$348.67M	0.55	-$22.75M	-$0.86	N/A

44.8% of InspireMD shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 34.1% of InspireMD shares are held by insiders. Comparatively, 1.5% of Inogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

InspireMD presently has a consensus target price of $4.50, suggesting a potential upside of 291.30%. Inogen has a consensus target price of $13.00, suggesting a potential upside of 85.19%. Given InspireMD's stronger consensus rating and higher possible upside, equities analysts clearly believe InspireMD is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Inogen	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

InspireMD has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500. Comparatively, Inogen has a beta of 1.64, indicating that its stock price is 64% more volatile than the S&P 500.

Summary

InspireMD beats Inogen on 10 of the 17 factors compared between the two stocks.

How does InspireMD compare to KORU Medical Systems?

InspireMD (NYSE:NSPR) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations.

In the previous week, InspireMD had 6 more articles in the media than KORU Medical Systems. MarketBeat recorded 14 mentions for InspireMD and 8 mentions for KORU Medical Systems. InspireMD's average media sentiment score of 0.73 beat KORU Medical Systems' score of 0.17 indicating that InspireMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InspireMD	4 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
KORU Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

InspireMD currently has a consensus price target of $4.50, suggesting a potential upside of 291.30%. KORU Medical Systems has a consensus price target of $7.25, suggesting a potential upside of 72.62%. Given InspireMD's stronger consensus rating and higher probable upside, analysts plainly believe InspireMD is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

KORU Medical Systems has higher revenue and earnings than InspireMD. KORU Medical Systems is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.85M	4.97	-$19.92M	-$0.73	N/A
KORU Medical Systems	$41.13M	4.69	-$2.64M	-$0.05	N/A

44.8% of InspireMD shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 34.1% of InspireMD shares are held by insiders. Comparatively, 18.5% of KORU Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

KORU Medical Systems has a net margin of -5.27% compared to InspireMD's net margin of -413.96%. KORU Medical Systems' return on equity of -13.61% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
KORU Medical Systems	-5.27%	-13.61%	-8.33%

InspireMD has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500.

Summary

InspireMD and KORU Medical Systems tied by winning 8 of the 16 factors compared between the two stocks.

Get InspireMD News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NSPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NSPR vs. The Competition

Export

Metric	InspireMD	Surgical & medical instruments Industry	Medical Sector	NYSE Exchange
Market Cap	$53.93M	$53.34M	$6.24B	$22.94B
Dividend Yield	N/A	1.08%	2.78%	4.02%
P/E Ratio	-1.53	13.76	17.86	25.94
Price / Sales	4.97	33.48	534.73	24.76
Price / Cash	N/A	18.87	43.07	25.21
Price / Book	0.63	12.60	9.97	4.63
Net Income	-$19.92M	-$20.48M	$3.55B	$1.07B
7 Day Performance	N/A	-3.77%	3.50%	0.47%
1 Month Performance	-14.18%	-5.56%	4.16%	4.11%
1 Year Performance	-55.77%	5.67%	41.82%	28.53%

InspireMD Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NSPR InspireMD	4.3627 of 5 stars	$1.15 -0.9%	$4.50 +291.3%	N/A	$53.93M	$10.85M	N/A	50	News Coverage Analyst Forecast Insider Trade
ELMD Electromed	1.9283 of 5 stars	$25.74 -1.0%	$36.67 +42.5%	N/A	$213.00M	$68.86M	34.32	160
INFU InfuSystem	4.1369 of 5 stars	$10.18 -4.5%	$15.00 +47.3%	N/A	$205.58M	$143.44M	169.69	410	News Coverage
CVRX CVRx	2.987 of 5 stars	$7.48 -2.2%	$10.50 +40.4%	N/A	$202.20M	$56.65M	N/A	160	News Coverage Upcoming Earnings Analyst Downgrade
INGN Inogen	3.2734 of 5 stars	$7.35 +1.4%	$11.00 +49.7%	N/A	$198.10M	$348.67M	N/A	1,030	Trending News Earnings Report High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NSPR) was last updated on 5/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

InspireMD (NSPR) Competitors

NSPR vs. ELMD, INFU, CVRX, INGN, and KRMD

How does InspireMD compare to Electromed?

Summary

How does InspireMD compare to InfuSystem?

Summary

How does InspireMD compare to CVRx?

Summary

How does InspireMD compare to Inogen?

Summary

How does InspireMD compare to KORU Medical Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NSPR vs. The Competition

InspireMD Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

InspireMD (NSPR) Competitors

NSPR vs. ELMD, INFU, CVRX, INGN, and KRMD

How does InspireMD compare to Electromed?

Is ELMD or NSPR more profitable?

Which has more volatility & risk, ELMD or NSPR?

Which has higher valuation and earnings, ELMD or NSPR?

Do analysts recommend ELMD or NSPR?

Do institutionals & insiders have more ownership in ELMD or NSPR?

Does the media prefer ELMD or NSPR?

Summary

How does InspireMD compare to InfuSystem?

Is INFU or NSPR more profitable?

Do institutionals and insiders hold more shares of INFU or NSPR?

Which has more volatility and risk, INFU or NSPR?

Does the media favor INFU or NSPR?

Do analysts recommend INFU or NSPR?

Which has higher earnings & valuation, INFU or NSPR?

Summary

How does InspireMD compare to CVRx?

Do analysts rate NSPR or CVRX?

Is NSPR or CVRX more profitable?

Which has better valuation & earnings, NSPR or CVRX?

Does the media refer more to NSPR or CVRX?

Which has more volatility and risk, NSPR or CVRX?

Do insiders & institutionals hold more shares of NSPR or CVRX?

Summary

How does InspireMD compare to Inogen?

Does the media favor NSPR or INGN?

Is NSPR or INGN more profitable?

Which has stronger valuation & earnings, NSPR or INGN?

Do institutionals & insiders hold more shares of NSPR or INGN?

Do analysts recommend NSPR or INGN?

Which has more volatility & risk, NSPR or INGN?

Summary

How does InspireMD compare to KORU Medical Systems?

Does the media favor NSPR or KRMD?

Do analysts recommend NSPR or KRMD?

Which has higher earnings & valuation, NSPR or KRMD?

Do institutionals & insiders hold more shares of NSPR or KRMD?

Is NSPR or KRMD more profitable?

Which has more risk and volatility, NSPR or KRMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NSPR vs. The Competition

InspireMD Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools